Evidence for a sustained fibrinolytic response to anisoylated plasminogen streptokinase activator complex in vitro.
Fears
R
R
Beecham Pharmaceuticals Research Division, Great Burgh, Epsom.
D016255:Anistreplase; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D010958:Plasminogen / Q000494:pharmacology*; D013300:Streptokinase / Q000494:pharmacology*
D005338:Fibrin Fibrinogen Degradation Products; D005343:Fibrinolytic Agents; D016255:Anistreplase; D010958:Plasminogen; D013300:Streptokinase